Stempoint Capital’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Sell |
386,790
-47
| -0% | -$531 | 1.4% | 24 |
|
|
2025
Q1 | $4.46M | Sell |
386,837
-605,966
| -61% | -$6.99M | 1.42% | 27 |
|
|
2024
Q4 | $8.41M | Buy |
+992,803
| New | +$8.41M | 2.1% | 17 |
|
|
2024
Q3 | – | Sell |
-736,765
| Closed | -$8.68M | – | 59 |
|
|
2024
Q2 | $8.68M | Sell |
736,765
-424,295
| -37% | -$5M | 2.55% | 15 |
|
|
2024
Q1 | $13.8M | Buy |
1,161,060
+737,886
| +174% | +$8.75M | 3.64% | 9 |
|
|
2023
Q4 | $5.18M | Buy |
+423,174
| New | +$5.18M | 1.38% | 24 |
|